U.S. stocks opened higher this morning, with the Dow Jones surging more than 200 points on Tuesday.
Following the market opening Tuesday, the Dow traded up 0.69% to 33,172.42 while the NASDAQ rose 0.78% to 12,679.19. The S&P also rose, gaining, 0.70% to 4,202.28.
Also check this: Executives Sell More Than $25M Of 4 Stocks
Leading and Lagging Sectors
Consumer staples shares climbed by 1.2% on Tuesday. Meanwhile, top gainers in the sector included Yatsen Holding Limited (NYSE:YSG), up 5% and US Foods Holding Corp. (NYSE:USFD) up 4%.
In trading on Tuesday, energy shares fell by 4.6%.
Top Headline
US producer prices rose 0.8% from a month ago in February, versus a revised 1.2% increase in the previous month and slightly below analysts’ estimates of 0.9%.
Equities Trading UP
Incannex Healthcare Limited (NASDAQ:IXHL) shares shot up 209% to $70.85 after jumping 54% on Monday. Incannex Healthcare recently completed a preliminary analysis of data from its Phase 2 trial of a cannabinoid combination product, IHL-42X, for obstructive sleep apnoea (OSA).
Shares of Butterfly Network, Inc. (NYSE:BFLY) got a boost, shooting 15% to $4.3091. FUJIFILM Sonosite recently filed patent infringement lawsuit against Butterfly Network.
AerSale Corporation (NASDAQ:ASLE) shares were also up, gaining 15% to $16.45 after the company reported better-than-expected Q4 adjusted EPS and sales results.
Equities Trading DOWN
Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) shares tumbled 41% to $1.7713 after the company reported Q4 results and issued weak FY22 sales outlook. Stifel downgraded Evolv Technologies from Buy to Hold and lowered the price target from $10 to $2.
Shares of Better Therapeutics, Inc. (NASDAQ:BTTX) were down 33% to $2.72. Better Therapeutics said data from its pivotal trial of BT-001, an investigational PDT platform that is designed to use digitally delivered nCBT to treat type 2 diabetes, demonstrated clinically meaningful and statistically significant results in improving glycemic control by reducing A1c 0.4% versus the control group receiving standard of care.
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) was down, falling 22% to $27.85 after the company reported downbeat Q4 earnings and issued weak FY22 sales forecast.
Also check out: Insiders Buying These 4 Penny Stocks
Commodities
In commodity news, oil traded down 5.3% to $97.54, while gold traded down 1.5% to $1,932.10.
Silver traded down 1.5% Tuesday to $24.92 while copper fell 0.7% to $4.4915.
Euro zone
European shares were lower today. The eurozone’s STOXX 600 fell 0.7%, London’s FTSE 100 fell 0.5%, while Spain’s IBEX 35 Index fell 0.1%. The German DAX dropped 0.9%, French CAC 40 dropped 0.9% and Italy’s FTSE MIB Index fell 0.5%.
French consumer price inflation rate accelerated to 3.6% year-over-year in February from 2.9% in the prior month. The UK unemployment rate fell to 3.9% during the three months to January 2022, recording the lowest level in two years, while number of people in work dropped by 12,000 on quarter to 32.493 million.
Economics
The Federal Open Market Committee begins its two-day policy meeting today.
US producer prices rose 0.8% from a month ago in February
The New York Empire State Manufacturing Index dropped 15 points to a reading of -11.8 in March.
The Treasury International Capital report for January will be released at 4:00 p.m. ET.
Check out this: Insiders Buy Around $21M Of 3 Stocks
Check out the full economic calendar here
COVID-19 Update
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 81,216,260 cases with around 991,030 deaths. India confirmed a total of at least 42,996,060 cases and 516,000 deaths, while Brazil reported over 29,382,190 COVID-19 cases with 655,320 deaths. In total, there were at least 460,312,530 cases of COVID-19 worldwide with more than 6,068,420 deaths.
